These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2060129)

  • 1. The clinical significance of cyclosporine metabolites.
    Yatscoff RW; Rosano TG; Bowers LD
    Clin Biochem; 1991 Feb; 24(1):23-35. PubMed ID: 2060129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of cyclosporine metabolites.
    Copeland KR; Thliveris JA; Yatscoff RW
    Ther Drug Monit; 1990 Nov; 12(6):525-32. PubMed ID: 2274998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW; McKenna RM
    Clin Chem; 1990 Feb; 36(2):225-9. PubMed ID: 2137384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.
    Copeland KR; Yatscoff RW
    Ther Drug Monit; 1991 Jul; 13(4):281-8. PubMed ID: 1780958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and biotransformation of the cyclosporine metabolite M-17 in the rabbit.
    Copeland K; Lukowski M; Yatscoff R; Thliveris J; Honcharik N
    Drug Metab Dispos; 1990; 18(2):226-30. PubMed ID: 1971578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of cyclosporin A: identification of 1,11 seco-cyclosporin A and 4,5 seco-isocyclosporin A by FAB-MS/MS.
    Magni F; Arnoldi L; Del Puppo M; Galli Kienle M
    Peptides; 1995; 16(8):1335-41. PubMed ID: 8745041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and structural identification of 9hydroxy-9desmethyl-cyclosporine.
    Bowers LD; Norman DD; Yan XX; Scheeler D; Carlson KL
    Clin Chem; 1990 Nov; 36(11):1875-9. PubMed ID: 2242562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunosuppressive activity of the aldehydic transformation of cyclosporine on alloreactive T-cells.
    Eiras G; Hashem H; Zeevi A; Wong L; Duquesnoy RJ; Burckart GJ
    J Clin Pharmacol; 1991 Jan; 31(1):72-5. PubMed ID: 2045531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and in vitro immunosuppressive activity of a SDZ-IMM-125 metabolite isolated from phenobarbital-induced rabbit liver microsomes.
    Dieden R; Verbeeck RK; Maton N; Latinne D; Lhoëst GJ
    Xenobiotica; 1997 Sep; 27(9):933-49. PubMed ID: 9381734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparative chromatographic purification of cyclosporine metabolites.
    Brooks CA; Cramer SM; Rosano TG
    Clin Chem; 1993 Mar; 39(3):457-66. PubMed ID: 8448857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of 10 cyclosporine metabolites from human bile.
    Wang CP; Hartman NR; Venkataramanan R; Jardine I; Lin FT; Knapp JE; Starzl TE; Burckart GJ
    Drug Metab Dispos; 1989; 17(3):292-6. PubMed ID: 2568911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric analysis of cyclosporine metabolites.
    Hartman NR; Jardine I
    Biomed Environ Mass Spectrom; 1986 Jul; 13(7):362-72. PubMed ID: 2943349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cyclosporine and cyclosporine metabolites in experimental small intestinal transplantation.
    Kim PC; Cohen Z; Wong PY; Cole E; Cullen J; Skorecki K; Cheung F; Fung LS; Craig M; Levy GA
    Transplantation; 1990 Jun; 49(6):1043-50. PubMed ID: 2360247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.
    Maurer G; Loosli HR; Schreier E; Keller B
    Drug Metab Dispos; 1984; 12(1):120-6. PubMed ID: 6141902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin analogs modified in the 3,7,8-positions: substituent effects on peptidylprolyl isomerase inhibition and immunosuppressive activity are nonadditive.
    Hu MK; Badger A; Rich DH
    J Med Chem; 1995 Oct; 38(21):4164-70. PubMed ID: 7473543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation of MeAla6-cyclosporin A by NMR. Relationship of sidechain orientation of the MeBmt-1, MeLeu-9, and MeLeu-10 residues to immunosuppressive activity.
    Gooley PR; Durette PL; Boger J; Armitage IM
    Int J Pept Protein Res; 1991 May; 37(5):351-63. PubMed ID: 1917291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and identification of a novel human metabolite of cyclosporin A: dihydro-CsA M17.
    Meier GP; Park SB; Yee GC; Gmur DJ
    Drug Metab Dispos; 1990; 18(1):68-71. PubMed ID: 1970780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding.
    Fesik SW; Gampe RT; Eaton HL; Gemmecker G; Olejniczak ET; Neri P; Holzman TF; Egan DA; Edalji R; Simmer R
    Biochemistry; 1991 Jul; 30(26):6574-83. PubMed ID: 2054356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4613-28. PubMed ID: 12361388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.